WASHINGTON, April 16, 2015 /PRNewswire-USNewswire/ — United Spinal Association, a national organization dedicated to enhancing the quality of life of all people living with spinal cord injuries and disorders (SCI/D), today urged Congress to hold oversight hearings to ensure FDA prioritizes safety for biosimilar medicines.